Zobrazeno 1 - 10
of 222
pro vyhledávání: ''
Autor:
Caroline Lions, N Biezunski, Sophie Matheron, Romain Guery, Pierre-Marie Roger, Caroline Charlier, Mathieu Dupont, Line Meddeb, Philippe Van de Perre, V Joly, R Lecomte, Matthieu Revest, Claudine Duvivier, B Lefèvre, M Delestan, H Laurichesse, H Marty, F Lemaitre, Martine Valette, Marc-Antoine Valantin, A S Ritleng, A Ménard, Eric Cua, M. Alvarez, A Raoux, M P Bouillon, A Sève, A Brebion, Claire Triffault-Fillit, Sylvie Bregigeon, M Carles, O. Aubry, S Hénard, P. Dellamonica, A Charmillon, E Alidjinou, V Brodard, M Tetart, F Raffi, Paul-Henri Consigny, O Lesens, C Brunet-Cartier, I Lamaury, S Giaché, Amandine Gagneux-Brunon, Jacques Reynes, Karine Sauné, Clotilde Allavena, Q Lepiller, Véronique Reliquet, C Louisin, I Perbost, Jean-Luc Berger, B Prouvost-Keller, Eric Delaporte, Isabelle Lamaury, C Gubavu, L Fagour, Laurent Cotte, G Gaube, Elina Teicher, Faouzi Souala, C Blanc, Dominique Merrien, Isabelle Poizot-Martin, C Drobacheff-Thiébaut, T May, P Richard, M A Trabaud, M Bistoquet, C Klotz, Samira Fafi-Kremer, M Marcel, Charlotte Charpentier, L Lelièvre, K Risso, Sandrine Pierre-François, S Ferrando, S Breaud, S Bevilacqua, A Montoya Ferrer, T Rojas-Rojas, D Boucher, Yazdan Yazdanpanah, Olivier Lortholary, Philippe Colson, Anne-Sophie Brunel, F-Xavier Lescure, Christelle Tomei, M Martin-Degioanni, Eric Rosenthal, Philippe Bossi, Patrick Miailhes, Kevin Bouiller, Lise Cuzin, A Foltzer, F Boulard, Michel Vidal, V Mondain, H Colson, J Pasquier, I Kmiec, F Alby-Laurent, R Agher, A Cabié, Guillaume Martin-Blondel, L Hocqueloux, M Colin, A Madrid, Faiza Ajana, J M Livrozet, V Rio, Karima Amazzough, C Merle de Boever, M Digumber, Thomas Perpoint, A Cheret, Laurence Bocket, Z Julia, Virginie Ferré, M Pradier, M Poisson-Vannier, A Legoff, M J Soavi, Y Quertainmont, Marine Morrier, Christian Chidiac, F Touam, O Zaegel-Faucher, A Marquise, G Benabdelmoumen, Florence Ader, T Guimard, M C Receveur, J C Tardy, P Morineau, K Guitteaud, D. Rey, S Leautez, Catherine Chirouze, Benoit Tressières, A. Ivanova, C Charre, J Reynes, Christian Pradier, Catherine Dhiver, Laurent Boyer, E Frentiu, David Rey, C Allavena, Anne Motte, Tristan Ferry, C Pronier, M. Hentzien, C Rouzaud, O Cabras, K Jidar, F Najioullah, C Clavel, M Orticoni, S Patrat-Delon, M Cavellec, Cécile Herrmann-Storck, V Baclet, Jade Ghosn, M Perry, S Wehrlen-Pugliese, J. M. Chapplain, R Palich, Laurent Hocqueloux, A Maillard, C Deschanvres, O Deradji, F. Lucht, A Grégoire, Veronique Joly, R Ouissa, C Daniel, N Mrozek, D Chirio, O Bollangier, J Bavay, P. Le Turnier, A Maka, C Rioux, Colin Deschanvres, C Brochier, Elisabeth Botelho-Nevers, A Meybeck, C Ceppi, J Lourenco, François Bénézit, Thomas Jovelin, G Zouzou, N Tissot, N. Viget, F Brunel-Dalmas, Brigitte Montes, N Chellum Rungen, K Rome, David Boutoille, B Bigeard, I Fabre, N Oran, M Lefebvre, P Point, C Etienne, Diane Descamps, G Thomas, S Le Gac, Cyrille Delpierre, Pierre Tattevin, M Godinot, P Fischer, C Aumeran, C Boulard, Elisabeth André-Garnier, J Sinteff, V Ronat, F Goehringer, Romain Palich, Luminita Schneider, I Touitou, Eric Billaud, P Thill, Catherine Varache, Olivier Robineau, I Jaquet, Roland Landman, Cédric Arvieux, B. Bonnet, V Rzepecki, Olivier Grossi, Christian Rabaud, L Laine, F Louni, C Cheneau, S Markowicz, Hélène Laroche, A Gervais, C Bernard-Henry, E Goncalvez, N Lerolle, M André, D Lambert, André Boibieux, L. Porte, S Bouchez, E Paredes, E Aïssi, V. Le Moing, S Degroodt, Sylvie Abel, André Cabié, B Lafon-Desmurs, O Babre, M Baldeyrou, C Debreux, A Rodallec, Pierre Delobel, V Icard, Agathe Becker, Edouard Tuaillon, Hervé Tissot-Dupont, M Mokhtari, C Morlat, I Alcaraz, Anne Frésard, O Cannesson, Elodie Curlier, P Chiarello, S. Roux, F Bani-Sadr, François Raffi, Florent Valour, M Piffaut, M Priester, A. Belkhir, J Romaru, Cécile Goujard, A Castro, G Cessot, A Mirand, C Pouderoux, A Brunet, C Michelangeli, Y N’guyen, Patrice Muret, Elisa Demonchy, Christine Jacomet, D Makhloufi, E Jeanmaire, Marialuisa Partisani, Véronique Obry-Roguet, J Turmel, C Mélounou, J. Durant, Christine Katlama, P Parize, O Robineau, S Seang, F. Bozon, S Galie, Alexa Debard, E de Mautort, C Duvivier, Fanny Lanternier, Alain Makinson, A Barrail-Tran, C Aguilar, A Naqvi, Rodolphe Garraffo, N Meftah, C Biron, A de Monte, Pascal Pugliese, V Corbin, S Jaureguiberry, E Lafont, L Hustache Mathieu, R Colarino, Isabelle Ravaux, C Henquell, Benoit Pilmis, M Grégoire, P Lansalot, E Ressiot, T. Huleux, Olivier Baud, S Sécher, R Dupin de Majoubert, J Leporrier, L Cuzin, E Chevalier, M Poinot, R Tubiana, S Lariven, A Boucher, N Atoui, Firouzé Bani-Sadr, T Prazuck, M Ducassou, Gilles Peytavin, A Soria, B J Gaborit
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 2022, 77 (1), pp.196-204. ⟨10.1093/jac/dkab367⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 77 (1), pp.196-204. ⟨10.1093/jac/dkab367⟩
Journal of Antimicrobial Chemotherapy, 2022, 77 (1), pp.196-204. ⟨10.1093/jac/dkab367⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 77 (1), pp.196-204. ⟨10.1093/jac/dkab367⟩
Background Maintenance ART with dolutegravir-based dual regimens have proved their efficacy among HIV-1-infected subjects in randomized trials. However, real-life data are scarce, with limited populations and follow-up. Objectives We assessed virolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033c18957dab579ab7bad3465386ebf0
https://hal.science/hal-03640621
https://hal.science/hal-03640621
Autor:
M.-P. Tavolacci, Tony Pereira, Thomas Duflot, Fabien Lamoureux, Frédéric Aubrun, Virginie Lvovschi, Robinson Joannides
Publikováno v:
CPT: Pharmacometrics and Systems Pharmacology
CPT: Pharmacometrics and Systems Pharmacology, 2021, ⟨10.1002/psp4.12735⟩
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 1, Pp 82-93 (2022)
CPT: Pharmacometrics and Systems Pharmacology, American Society for Clinical Pharmacology and Therapeutics ; International Society of Pharmacometrics, 2021, ⟨10.1002/psp4.12735⟩
CPT: Pharmacometrics and Systems Pharmacology, 2021, ⟨10.1002/psp4.12735⟩
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 1, Pp 82-93 (2022)
CPT: Pharmacometrics and Systems Pharmacology, American Society for Clinical Pharmacology and Therapeutics ; International Society of Pharmacometrics, 2021, ⟨10.1002/psp4.12735⟩
Intravenous (i.v.) morphine is a safe, robust, and recommended treatment for severe pain using the titration principle. Despite its high efficacy, it is impacted by organizational constraints related to venous access. Nebulized (NEB) morphine may rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b1916efced1f03423e453f1c4a58995
https://hal-normandie-univ.archives-ouvertes.fr/hal-03483329
https://hal-normandie-univ.archives-ouvertes.fr/hal-03483329
Autor:
Rithea Leang, Didier Leroy, Melissa Mairet-Khedim, Camille Roesch, Sopheakvatey Ke, Steven P. Maher, Benoit Witkowski, Flore Nardella
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 76 (10), pp.2565-2568. ⟨10.1093/jac/dkab219⟩
Journal of Antimicrobial Chemotherapy, 2021, 76 (10), pp.2565-2568. ⟨10.1093/jac/dkab219⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 76 (10), pp.2565-2568. ⟨10.1093/jac/dkab219⟩
Journal of Antimicrobial Chemotherapy, 2021, 76 (10), pp.2565-2568. ⟨10.1093/jac/dkab219⟩
Background Expanding resistance to multiple antimalarials, including chloroquine, in South-East Asia (SEA) urges the development of new therapies. AQ-13, a chloroquine derivative, is a new drug candidate for treating malaria caused by Plasmodium falc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7faa25403d75d2b87d724e853a93c0
https://hal-pasteur.archives-ouvertes.fr/pasteur-03480931/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-03480931/document
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 76 (10), pp.2586-2592. ⟨10.1093/jac/dkab236⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2021, 76 (10), pp.2586-2592. ⟨10.1093/jac/dkab236⟩
ObjectivesTo assess performance of disc diffusion, gradient tests and Vitek 2 system to determine the susceptibility of clinical Pseudomonas aeruginosa strains to ceftolozane/tazobactam (C/T) and ceftazidime/avibactam (CZA).MethodsTwo-hundred non-dup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69811d9859ba3e81e5d98eb50a20c581
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03483278
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03483278
Autor:
Damien Dupont, John D. Turnidge, J Fuller, Maiken Cavling Arendrup, A Forastiero, M Dehais, Emilia Cantón, Hélène Guegan, Nathalie Bourgeois, Ana Espinel-Ingroff, Guillermo Garcia-Effron, Laurence Delhaes, B. Bouteille, Teresa Peláez, J Garcia, Cornelia Lass-Flörl, Jesús Guinea, Arnaud Fekkar, Nelesh P. Govender, Françoise Botterel, Eric Dannaoui, Gloria M. González, R Magobo, Sophie Cassaing, Michaela Lackner, Milène Sasso, Sandrine Houzé
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, pp.AAC0109321. ⟨10.1128/AAC.01093-21⟩
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Antimicrobial Agents and Chemotherapy, 2021, 65 (11), pp.AAC0109321. ⟨10.1128/AAC.01093-21⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, pp.AAC0109321. ⟨10.1128/AAC.01093-21⟩
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Antimicrobial Agents and Chemotherapy, 2021, 65 (11), pp.AAC0109321. ⟨10.1128/AAC.01093-21⟩
International audience; Susceptibility testing is an important tool in the clinical setting; its utility is based on the availability of categorical endpoints, breakpoints (BPs) or epidemiological cutoff values (ECVs/ECOFFs). CLSI and EUCAST have dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701599d1aaad957f533fd2f731b35463
https://hal.archives-ouvertes.fr/hal-03355996
https://hal.archives-ouvertes.fr/hal-03355996
Autor:
Jay Zhang, Vincent Benn, Mark Bush, Y. Fred Yang, Shuangshuang Chi, Ping Wang, Jinrong Liu, Xiaojuan Tan, Frederic Jaisser
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.604928⟩
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.604928⟩
Frontiers in Pharmacology, Vol 12 (2021)
The therapeutic indices (TIs) and efficacy of the non-steroidal mineralocorticoid receptor antagonist (MRA) KBP-5074 and steroidal MRA eplerenone were evaluated in a uninephrectomized Sprague Dawley rat model of aldosterone-mediated renal disease. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c065ebc8bd5e1f1804a38449087fb2d
https://hal.sorbonne-universite.fr/hal-03285721/file/fphar-12-604928.pdf
https://hal.sorbonne-universite.fr/hal-03285721/file/fphar-12-604928.pdf
Publikováno v:
OncoTargets and Therapy
OncoTargets and Therapy, Dove Medical Press, 2021, Volume14, pp.3949-3958. ⟨10.2147/ott.s312889⟩
OncoTargets and therapy
OncoTargets and Therapy, Dove Medical Press, 2021, Volume14, pp.3949-3958. ⟨10.2147/ott.s312889⟩
OncoTargets and therapy
Brice Leyrat,1,2 Xavier Durando,1â 5 Hugo Veyssiere,3â 5 Maureen Bernadach1,3â 5 1Département dâOncologie Médicale, Centre Jean Perrin, Clermont-Ferrand, 63011, France; 2Université Clermont Auvergne, UFR Médecine, Cler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7122935b2a39ef625b42e318e07459
https://hal.archives-ouvertes.fr/hal-03294091/file/ott-14-3949.pdf
https://hal.archives-ouvertes.fr/hal-03294091/file/ott-14-3949.pdf
Autor:
Alain Bousquet-Mélou, Isabelle Bargues, Jean-François Sutra, Pierre-Louis Toutain, Anne Lespine
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.666348⟩
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.666348⟩
Frontiers in Pharmacology, Vol 12 (2021)
Ivermectin (IVM) and moxidectin (MOX) are used extensively as parasiticides in veterinary medicine. Based on in vitro data, IVM has recently been proposed for the prevention and treatment of COVID-19 infection, a condition for which obesity is a majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ce3c2ce745c41f311166012965c26f
https://hal.inrae.fr/hal-03260114
https://hal.inrae.fr/hal-03260114
Publikováno v:
Current Neuropharmacology
Current Neuropharmacology, Bentham Science Publishers, 2021, 19 (5), pp.591-609. ⟨10.2174/1570159X18666200729103529⟩
Current Neuropharmacology, 2021, 19 (5), pp.591-609. ⟨10.2174/1570159X18666200729103529⟩
Current Neuropharmacology, Bentham Science Publishers, 2021, 19 (5), pp.591-609. ⟨10.2174/1570159X18666200729103529⟩
Current Neuropharmacology, 2021, 19 (5), pp.591-609. ⟨10.2174/1570159X18666200729103529⟩
Tetrahydrobipterin (BH4) is a pivotal enzymatic cofactor required for the synthesis of serotonin, dopamine and nitric oxide. BH4 is essential for numerous physiological processes at periphery and central levels, such as vascularization, inflammation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48a9a9e8c9bcef94db2457e677ea81a
https://hal.inrae.fr/hal-03279731
https://hal.inrae.fr/hal-03279731
Autor:
Marie Selvy, Nicolas Kerckhove, Bruno Pereira, Fantine Barreau, Daniel Nguyen, Jérôme Busserolles, Fabrice Giraudet, Aurélie Cabrespine, Carine Chaleteix, Martin Soubrier, Jacques-Olivier Bay, Richard Lemal, David Balayssac
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.637593⟩
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.637593⟩
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.637593⟩
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.637593⟩
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is associated with psychological distress and a decrease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f95125e1cfd870a8765899f4b3736bb
https://hal.inrae.fr/hal-03238418/document
https://hal.inrae.fr/hal-03238418/document